CRMT
America's Car-Mart, Inc.
There isn't enough reported data to score CRMT yet.
F
Ford Motor Company
F lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
CRMT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Healthy | |
| Strong |
CRMT's cash flow and balance sheet are currently healthy, but its revenue and profitability are weak.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CRMT PE Valuation
CRMT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 1.1x next year's earnings.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CRMT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CRMT to return to profit, with revenue declining.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
F has the edge over CRMT on the outlook, with more favorable revenue expectations.
CRMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q3 2026 | -$24.38 | -1462% |
| Q2 2026 | -$16.79 | -821% |
| Q1 2026 | -$11.15 | -1312% |
| Q4 2025 | -$1.53 | -$0.74 |
| Q3 2025 | $1.79 | +$7.49 |
| Q2 2025 | $2.33 | +$7.25 |
| Q1 2025 | $0.92 | +$5.60 |
| Q4 2024 | -$0.79 | +$2.32 |
CRMT has the edge over F on earnings, with more consistent year-over-year improvement.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
CRMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $145.8M | -57% |
| Q2 2026 | $302.8M | -18% |
| Q1 2026 | $286.8M | -12% |
| Q4 2025 | $350.2M | +0.8% |
| Q3 2025 | $341.3M | -1.9% |
| Q2 2025 | $370.2M | +1.5% |
| Q1 2025 | $325.7M | +8.7% |
| Q4 2024 | $347.3M | -4% |
CRMT's revenue has slid since its 2023 peak: $146M last quarter, down 57% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -47% | -45 points |
| Q2 2026 | -12% | -15 points |
| Q1 2026 | -13% | -14 points |
| Q4 2025 | -7.8% | -9.9 points |
| Q3 2025 | -2.2% | -1.8 points |
| Q2 2025 | 3.4% | +3.2 points |
| Q1 2025 | 1.4% | +4.8 points |
| Q4 2024 | 2% | +12 points |
CRMT's operating margin was −47% last quarter, down 45 points from the same quarter a year ago, near the bottom of its range since 2019.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over CRMT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F has the edge over CRMT on profitability, with a higher operating margin.
CRMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $80M | +$86.4M |
| Q2 2026 | $67.4M | +266% |
| Q1 2026 | -$6.2M | +$25.3M |
| Q4 2025 | $8.3M | +$31.9M |
| Q3 2025 | -$6.4M | +$9.6M |
| Q2 2025 | $18.4M | +$30.4M |
| Q1 2025 | -$31.5M | -408% |
| Q4 2024 | -$23.6M | +$7.9M |
CRMT has the edge over F on cash flow, with more consistent year-over-year improvement.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.
CRMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2023 | -0.3x | Net Cash |
| Q2 2023 | 5.1x | High |
| Q4 2022 | 3.5x | Elevated |
| Q3 2022 | 1.7x | Healthy |
CRMT has more cash than debt.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has more cash than debt.
CRMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.1 | Oversold |
| Stochastic | 18.7 | Oversold |
CRMT's weekly RSI is 28 (oversold) and its Stochastic is 19 (oversold).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CRMT PE vs Consumer Cyclical Sector
| Metric | CRMT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CRMT has no meaningful PE right now: it lost money over the past year.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CRMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.09 | 15% below |
| 20 week MA | $2.09 | 56% below |
| 50 week MA | $11.0 | 92% below |
| 100 week MA | $27.0 | 97% below |
| 200 week MA | $49.6 | 98% below |
CRMT is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CRMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.6 | $110.0 | +1.3% |
| 2021 | $110.0 | $102.8 | -6.5% |
| 2022 | $102.8 | $72.1 | -30% |
| 2023 | $72.1 | $75.8 | +5.1% |
| 2024 | $75.8 | $52.3 | -31% |
| 2025 | $52.3 | $25.9 | -51% |
| 2026 YTD | $25.9 | $0.93 | -96% |
CRMT has finished lower in four of the last six years. It's down 96% so far in 2026.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F has the edge over CRMT on returns for 2026, with the stronger performance.